All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Clinical comparison

Colistin (Polymyxin E) vs Sincalide (Kinevac)

An educational, source-based comparison of Colistin (Polymyxin E) and Sincalide (Kinevac) — how each peptide works, what it's researched for, and what to know before going deeper.

Polymyxin · Infectious Disease
Colistin (Polymyxin E)

Last-resort lipopeptide antibiotic for multidrug-resistant Gram-negatives.

Mechanism

Cationic cyclic lipopeptide that disrupts the outer membrane of Gram-negative bacteria by binding lipid A of LPS, causing membrane permeability and cell death.

Research areas
  • Carbapenem-resistant Acinetobacter, Klebsiella, Pseudomonas
Considerations
  • FDA-approved.
  • Nephrotoxicity and neurotoxicity dose-limiting.
Full Colistin (Polymyxin E) profile →
CCK Analog · Diagnostics
Sincalide (Kinevac)

Synthetic C-terminal octapeptide of cholecystokinin for gallbladder imaging.

Mechanism

Synthetic CCK-8 that binds CCK-A receptors on gallbladder smooth muscle, triggering contraction; used to assess gallbladder ejection fraction in cholescintigraphy.

Research areas
  • Gallbladder ejection fraction (HIDA scan)
  • Pancreatic secretion testing
  • Small bowel transit imaging
Considerations
  • FDA-approved.
  • Abdominal cramping, nausea, diarrhea common; contraindicated in suspected gallstone obstruction.
Full Sincalide (Kinevac) profile →

Colistin (Polymyxin E) vs Sincalide (Kinevac) — Key differences

  • Class: Colistin (Polymyxin E) is classified as Polymyxin · Infectious Disease, while Sincalide (Kinevac) is CCK Analog · Diagnostics.
  • Primary research focus: Colistin (Polymyxin E)carbapenem-resistant acinetobacter, klebsiella, pseudomonas; Sincalide (Kinevac)gallbladder ejection fraction (hida scan).
  • Tag: FDA-Approved · Antibiotic vs FDA-Approved · Diagnostics.

Related comparisons